Paper Review Records
All Paper Review Records
15 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
A tumor-microenvironment-responsive M1 macrophage-membrane-camouflaged nanoplatform potentiates polyphyllin VII immunotherapy through disrupting the ASNS-mTOR axis and inducing immunogenic cell death for solid tumor treatment
Wenya Su; Luyao Tian; Hongyan Xu; Juan Wang; Xia Li; Wenyuan GaoShow moreShow less
School of Pharmaceutical Science and Technology, Faculty of Medicine, Tianjin University, Tianjin, ChinaShow moreShow less
Simple heat-assisted method for mRNA loading into empty lipid nanoparticles enables robust in vitro and in vivo delivery
Takayuki Miyazaki; Kenji Kubara; Keita Kondo; Hiroshi Kamiyama; Shoki Hara; Jun Moriya; Hiroshi Ishihara; Yuta SuzukiShow moreShow less
Tsukuba Research Laboratories, Eisai Co., Ltd., 5-1-3, Tokodai, Tsukuba, Ibaraki 300-2635, Japan; Formulation Research Laboratories, Pharmaceutical Science and Technologies, Eisai Co., Ltd., 1 Kawashimatakehaya-machi, Kakamigahara, Gifu, 501-6195, Japan; Laboratory of Formulation Science and Technology, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences, 1432-1, Horinouchi, Hachioji, Tokyo 192-0392, JapanShow moreShow less
Impact of the protein corona in RGD-functionalized nanoliposomes delivering enzymatic replacement therapy for Fabry disease
Marc Moltó-Abad; Judit Tomsen-Melero; Verónica Villagrasa-Araya; Daniel Marijuan-Pinel; Zamira V. Díaz-Riascos; Francesc Canals; Luna Martín; Guillem Pintos-Morell; Sandra Mancilla; Belén García; Aida Carreño; Albert Font; Simó Schwartz; Roser Ferrer; Nora Ventosa; Elisabet González-Mira; Ibane AbasoloShow moreShow less
Clinical Biochemistry Drug Delivery and Therapy Group (CB-DDT), Vall d’Hebron Research Institute (VHIR), Vall d’Hebron University Hospital Research Institute (ISS IRHUVH), Barcelona, 08035, Spain; Centro de Investigación Biomédica en Red, Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Barcelona, 08034, Spain; Institute of Material Science of Barcelona (ICMAB-CSIC), Campus UAB, 08193 Bellaterra, Spain; Institute for Advanced Chemistry of Catalonia (IQAC-CSIC), Barcelona 08034, Spain; Proteomics Group, Vall d’Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital Research Institute (ISS IRHUVH), Barcelona, 08035, Spain; Delbios Pharmaceuticals, Parc de Recerca de la UAB, Bellaterra, 08193, Spain; Leanbio SL, 08028 Barcelona, Spain; Servei de Bioquímica, Hospital Universitari Vall d’Hebron, 08035 Barcelona, Spain; Nanomol Technologies SL, Campus de la UAB, 08193 Bellaterra, SpainShow moreShow less
Subcutaneous mesoporous silica formulation modulates systemic and tumor-associated paclitaxel exposure in a B16F10 melanoma model
Jihoon Lee; Min-Koo Choi; Sang-Cheol Han; Yong-Il Shin; In Jun Yeo; Im-Sook SongShow moreShow less
BK21 FOUR Community-Based Intelligent Novel Drug Discovery Education Unit, Vessel–Organ Interaction Research Center (VOICE), College of Pharmacy and Research Institute of Pharmaceutical Sciences, Kyungpook National University, Daegu, 41566, the Republic of Korea; College of Pharmacy, Dankook University, Cheonan, 31116, the Republic of Korea; CEN Co., Ltd., Miryang, Gyeongsangnam-do, 50404, the Republic of Korea; Department of Rehabilitation Medicine, Pusan National University School of Medicine, Yangsan, Gyeongsangnam-do, 50612, the Republic of KoreaShow moreShow less
Effect of human skin storage on stratum corneum drug penetration assessed by confocal Raman spectroscopy
Jakob Schmolz; Diana Cerbu; Stefanie Barker; Christian Freystätter; Adelheid Elbe-Bürger; Victoria KlangShow moreShow less
Department of Pharmaceutical Sciences, University of Vienna, Josef-Holaubek-Platz 2, Vienna, 1090, Austria; Vienna Doctoral School of Pharmaceutical, Nutritional and Sport Sciences, University of Vienna, Josef-Holaubek-Platz 2, Vienna, 1090, Austria; Department of Dermatology, Medical University of Vienna, Währinger Gürtel 18–20, Vienna, 1090, Austria; Department of Plastic, Reconstructive and Aesthetic Surgery, Medical University of Vienna, Währinger Gürtel 18–20, Vienna, 1090, AustriaShow moreShow less
A dual functional hybrid lipid-polymeric nanoparticle co-loaded coenzyme Q10 and siRNA TNFα for anti-inflammatory skin therapy
Ana Vitória Pupo Silvestrini; Milena Finazzi Morais; Thatiani Figueiredo dos Santos; Ana Paula Ramos; Maria Vitória Lopes Badra BentleyShow moreShow less
School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, 14040-903 Ribeirão Preto, SP, Brazil; Department of Chemistry, Faculty of Philosophy, Sciences and Letters at Ribeirão Preto, University of São Paulo, Ribeirão Preto, SP, BrazilShow moreShow less
FAQ
How long does International Journal of Pharmaceutics take to review a manuscript?
As of 2026-11-13, CrushSCI has 15 complete review records for International Journal of Pharmaceutics. The fastest paper went from submission to acceptance in 34 days (Polysaccharide-functionalized metal-polyphenol network-coated porous microspheres for improving the treatment of probiotics in ulcerative colitis, received 2026-07-24, accepted 2026-08-27); the slowest took 211 days. The average is 97.2 days and the median is 83 days.
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
